| Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978) |
|---|
| 02/06/2013 | EP2554541A1 Therapeutic agent or prophylactic agent for fibromyalgia |
| 02/06/2013 | EP2552888A1 "trpv1 vanilloid receptor antagonists with a bicyclic portion" |
| 02/06/2013 | CN102918031A Radiolabeled compounds and methods thereof |
| 02/06/2013 | CN102911133A Purification method of (4R,5R)-2- dichloromethyl-4,5- dihydro-5-(4-methylsulfonyl-phenyl)-4-oxazol methanol |
| 02/06/2013 | CN102911132A Method for preparing docetaxel chiral side chain and immediate thereof |
| 02/06/2013 | CN101778834B Novel herbicides |
| 02/05/2013 | CA2539767C 1,3-benzoxazolyl derivatives as kinase inhibitors |
| 01/31/2013 | WO2013014314A2 Derivatives of 5-azolone as calpain inhibitors |
| 01/31/2013 | WO2013014204A2 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/31/2013 | US20130030180 Methods of Facilitating Neural Cell Survival Using GDNF Family Ligand (GFL) Mimetics or RET Signaling Pathway Activators |
| 01/31/2013 | US20130030029 Glucagon Antagonists |
| 01/31/2013 | CA2841905A1 3-heteroaroylamino-propionic acid derivatives and their use as pharmaceuticals |
| 01/30/2013 | CN102906076A Combretastatin derivative preparation method |
| 01/30/2013 | CN102898395A Method for preparing 4-methyl-5-(n-butoxy)oxazole |
| 01/30/2013 | CN102898394A Method for preparing linezolid |
| 01/30/2013 | CN102898393A Method for synthesizing chiral oxazoline |
| 01/29/2013 | US8362264 Compositions and methods for the treatment of disease associated with Trp-p8 expression |
| 01/29/2013 | US8362020 Hepatitis C virus inhibitors |
| 01/29/2013 | CA2537345C Intermediates for the preparation of oxazolidinone-quinolone hybrids |
| 01/24/2013 | WO2013012500A1 Trpv4 antagonists |
| 01/24/2013 | CA2839743A1 Trpv4 antagonists |
| 01/23/2013 | CN102887871A Preparation method of 3-substituted phenyl-5-(aminomethyl) oxazolidin-2-one |
| 01/23/2013 | CN101565393B 3-(substituted bisulfonyl fluromethane)-1-propylene compound, synthetic method and applications thereof |
| 01/22/2013 | US8357712 4,5-dihydro-oxazol-2yl derivatives |
| 01/22/2013 | CA2672271C Compounds and compositions as inhibitors of cannabinoid receptor 1 activity |
| 01/22/2013 | CA2565695C Certain chemical entities and compositions for use in the treatment of a cellular proliferative disease or disorder |
| 01/17/2013 | US20130018159 Copolymerizable methine and anthraquinone compounds and articles containing them |
| 01/17/2013 | US20130018054 New compounds |
| 01/17/2013 | US20130018048 Oxazole derivatives useful as modulators of faah |
| 01/16/2013 | CN102875486A Preparation method of 2-benzoxazole acetonitrile |
| 01/15/2013 | US8354538 Small-molecule inhibitors of the androgen receptor |
| 01/15/2013 | US8354441 Oxazoline derivatives |
| 01/15/2013 | US8354436 IL17 and IFN-gamma inhibition for the treatment of autoimmune inflammation |
| 01/10/2013 | WO2013006758A1 Diphosphate mimetics and uses thereof |
| 01/10/2013 | WO2013004190A1 Amino-propylene-glycol derivatives, preparation method and pharmaceutical composition and use thereof |
| 01/10/2013 | WO2013004075A1 Tumor targeted drug combretastatin a4 derivative |
| 01/10/2013 | WO2012141487A3 Cycloalkenyl aryl derivatives for cetp inhibitor |
| 01/10/2013 | US20130012719 Convenient Synthesis of Azolines to Azoles |
| 01/10/2013 | US20130012514 Aminoalkyloxazole and aminoalkylthiazolecarboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 01/10/2013 | US20130012513 Hedgehog inhibitors |
| 01/10/2013 | US20130012502 Pharmaceutical or Veterinary Antiviral Compositions |
| 01/10/2013 | CA2839942A1 Tumor-targeted drug combretastatin a4 derivatives |
| 01/09/2013 | EP2542081A1 Compounds for treatment of cancer |
| 01/09/2013 | CN102863388A Tumor targeted drug Combretastatin A4 derivatives |
| 01/09/2013 | CN102863345A Amino propylene glycol derivative, preparation method of amino propylene glycol derivative, medicine composition of amino propylene glycol derivative and application of amino propylene glycol derivative |
| 01/09/2013 | CN102180841B 2-bromodifluoromethyl substituted 1,3-oxazoline compound and synthesis method thereof |
| 01/08/2013 | US8349874 Cyclohexane derivative and pharmaceutical use thereof |
| 01/03/2013 | WO2013000085A1 Selective glycosidase inhibitors and uses thereof |
| 01/03/2013 | WO2012116151A3 Vinyl -aryl - sulfones for use in peritoneal carcinomatosis |
| 01/03/2013 | US20130005984 11c-labeled benzophenone/benzoxazole analogues as an inflammation imaging agent |
| 01/03/2013 | US20130005736 Antiviral agents |
| 01/03/2013 | US20130005730 Novel 1,3-oxazolidine compounds and their use as renin inhibitors |
| 01/02/2013 | EP2540698A1 Method for making phenylethylamine compounds |
| 01/02/2013 | CN102858748A Therapeutic agent and preventative agent for Alzheimer's disease |
| 01/02/2013 | CN102858742A Trpv1 vanilloid receptor antagonists with a bicyclic portion |
| 01/02/2013 | CN102850390A Intermediate of ezetimibe and its preparation method |
| 01/02/2013 | CN102850290A Preparation method of crystal form I linezolid |
| 01/02/2013 | CN102850289A Linezolid crystal form VI and preparation method thereof |
| 01/02/2013 | CN102850288A Method for preparing linezolid |
| 01/02/2013 | CN101516856B Heterocyclic bridged biphenyls and their use in oleds |
| 01/02/2013 | CN101384532B Process for preparing optically active alcohols |
| 01/02/2013 | CN101365681B Iminopropene compound and use thereof |
| 01/01/2013 | US8344002 Compound having β-secretase inhibitory activity |
| 01/01/2013 | US8343970 PDE10 inhibitors and related compositions and methods |
| 01/01/2013 | US8343639 Organic semiconductor material and light-emitting element, light-emitting device, lighting system, and electronic device using the same |
| 12/27/2012 | WO2012175304A1 Process for 4-methyloxazole-5-carboxamide |
| 12/27/2012 | DE102011088854A1 Preparing O-amino-hydroxy-octadec-en-yl phosphate useful for preparing sphingosine-1-phosphate, comprises oxidizing substituted oxazolidin-yl-methanol derivative and reacting substituted carbaldehyde derivatives with alkyne compounds |
| 12/26/2012 | CN102070548B Evaporation crystallization process for linezolid with crystal form I |
| 12/26/2012 | CN101941950B 2-substituted benzo-[d] oxazole-5-propionic acid compound and preparation method and applications thereof |
| 12/26/2012 | CN101804047B Antimicrobial and radioprotective compounds |
| 12/25/2012 | US8338617 Process for preparing oxazolidine derivatives |
| 12/25/2012 | US8338459 Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 12/20/2012 | WO2012173572A1 Stereoselective synthesis of highly substituted enamides |
| 12/20/2012 | WO2012171248A1 1,3-oxazolidine-2-one-like compound, preparation method and uses thereof |
| 12/20/2012 | US20120323015 Oxadiazole Derivative, Light-Emitting Element Material, Light-Emitting Element, Light-Emitting Device, and Electronic Device |
| 12/19/2012 | EP2534139A1 Novel aminoalkyl-oxazole and aminoalkyl-thiazole carboxylic acid amides as regeneration-promoting substances for sensory organs and post-mitotic tissue |
| 12/19/2012 | CN102225915B Chiral oxazoline and synthesis method thereof |
| 12/19/2012 | CN102093303B (2R, 4S)-4-phenyl-2-methyl-2-trifluoromethyl oxazoline and preparation method thereof |
| 12/19/2012 | CN101443330B Heterocycle non-nucleosides compound and preparation method thereof, medicament composition and purpose as antivirus antivirus inhibitor |
| 12/18/2012 | US8334316 Substituted organosulfur compounds and methods of using thereof |
| 12/18/2012 | US8334290 CETP inhibitors |
| 12/18/2012 | CA2754102C Monoclonal antibodies and compositions comprising such useful for inhibition of .alpha.v.beta.5 mediated angiogenesis |
| 12/18/2012 | CA2533812C Substituted cycloalkylidene compounds |
| 12/12/2012 | CN102822152A Novel 1,3-oxazolidine compounds and their use as renin inhibitors |
| 12/12/2012 | CN102822148A Therapeutic agent or prophylactic agent for fibromyalgia |
| 12/12/2012 | CN101801941B Pharmaceutical containing ppar delta agonist |
| 12/12/2012 | CN101223150B Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate |
| 12/11/2012 | US8329918 Selective alpha 2B/2C agonists |
| 12/11/2012 | US8329706 Oxazolidinone derivatives |
| 12/11/2012 | CA2647819C Phenylcyclohexyl derivatives as dgat1 inhibitors |
| 12/11/2012 | CA2563975C Compounds and compositions as cathepsin s inhibitors |
| 12/11/2012 | CA2535704C Aminopropanol derivatives |
| 12/06/2012 | WO2012166463A2 Aminooxazole inhibitors of cyclin dependent kinases |
| 12/06/2012 | WO2012165314A1 Amide compound |
| 12/06/2012 | US20120309724 Neprilysin inhibitors |
| 12/05/2012 | EP2528890A1 Aminocyclohexanes and aminotetrahydropyrans and related compounds as gamma-secretase modulators |
| 12/05/2012 | CN1893977B Remedies for diseases with bone mass loss having ep4 agonist as the active ingredient. |
| 12/05/2012 | CN102812008A Therapeutic agent or preventive agent for urine collection disorder |
| 12/05/2012 | CN102807531A 1h-quinaz0line-2,4-diones and their use as ampa-receptor ligands |
| 12/05/2012 | CN101801928B Novel cyclo-dione herbicides |